Medical breakthrough may help treat colitis and fight colorectal tumors
A new study, from the Tokyo University of Science (TUS) reports on an antibody and an immunoreceptor protein with roles in reducing colitis severity and colon tumor growth.
A new study, from the Tokyo University of Science (TUS) reports on an antibody and an immunoreceptor protein with roles in reducing colitis severity and colon tumor growth.
The findings back previous studies that also advocate for the large-scale use of gold nanoparticles as the primary treatment option for IBD patients.
The results showed the pregnant women with IBD had higher incidences of common pregnancy complications.
Artificial intelligence is becoming a powerful tool within the medical community.
Bone broth has become increasingly popular, especially among wellness enthusiasts and gut health fanatics.
The exact cause of IBD is unknown, but one group of researchers suggests it could be the work of toxin-producing yeast strains in the gut.
Receiving the COVID-19 vaccination strengthened one type of immune response to the SARS-CoV-2 virus in inflammatory bowel disease (IBD) patients.
A new study reveals that the more antibiotics prescribed to patients 60 and older, the more likely they were to develop inflammatory bowel disease (IBD).
New research suggests there is a way to optimize treatments for inflammatory bowel disease, or IBD.
Researchers found that glial cells coordinate immune responses of the gut following pathogen invasion or insult to the tissues.